Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Current Size And Growth Outlook For The Pediatric Vaccine Market?

In recent times, the pediatric vaccine market has experienced robust growth. There is an expectation of the market expanding from $44.2 billion in 2024 to $46.95 billion in 2025 with a compound annual growth rate (CAGR) of 6.2%. The substantial growth in the preceding period can be attributed to factors such as the rise in chronic illnesses, policies advocating for immunization to eliminate endemic ailments, and an increase in the funding allocated to vaccine development.

Anticipated robust expansion is on the horizon for the pediatric vaccine market, with predictions suggesting an escalation to $62.48 billion by 2029, boasting a compound annual growth rate (CAGR) of 7.4%. Factors propelling this predicted growth over the forecasted period include the surge in invasive cervical cancer cases, robust late-stage pipeline coupled with the approvals of new drugs, and the rising occurrence of infectious diseases. Key trends shaping this forecasted period are the development of combination vaccines to cater to market needs, prioritizing research and development efforts to create effective vaccines, a focus on crafting live attenuated vaccines, employing cutting-edge immune engineering and superior delivery systems, and integrating artificial intelligence (AI) in the vaccine development process to streamline procedures and facilitate production.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

What Growth-Enabling Forces Are Impacting The Pediatric Vaccine Market?

The pediatric vaccines market is expected to grow due to the increasing occurrence of chronic conditions such as tuberculosis, diphtheria and pneumonia in children aged 15 and below. Children and teenagers with chronic health conditions face a higher risk of severe consequences and complications from infectious diseases. An Australia-based entity, the Australian Bureau of Statistics, reported in March 2022 that about half of the total population (46.6%, or 11.6 million) had a minimum of one chronic disease. The rising count of chronic diseases in children escalates the need for immunization against these diseases, providing a stimulus to the growth of the pediatric vaccine market.

What Segmentation Insights Are Provided In The Pediatric Vaccine Market Research?

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

Which Notable Trends Are Transforming The Pediatric Vaccine Market Outlook?

The need for innovative vaccines is consistently rising to provide better protection against difficult infectious diseases (for example, tuberculosis, HIV/AIDS) and persistent non-transmittable diseases like cancer and neurodegenerative ailments. New methods in vaccine development encompass structure-based immunogenic design, gene-oriented vaccine platforms, and efficient adjuvant recombinant antigen formulations. Given the escalating demand for new vaccines, there is an ongoing push among pediatric vaccine manufacturers and developers to innovate vaccine design and production technologies. For example, in April 2023, Pfizer Inc., a pharmaceutical manufacturer based in the US, announced the U.S. FDA’s approval of REVNAR 20, a Pneumococcal Conjugate Vaccine with 20 valences for young children and infants.

Which Companies Are Contributing Significantly To The Pediatric Vaccine Market Growth?

Major companies operating in the pediatric vaccine market include Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd, Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught LaboratoriesInc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Pediatric Vaccine Market?

North America was the largest region in the pediatric vaccine market in 2024. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2824&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model